Comparative efficacy and safety of anticoagulant, combination, and antiplatelet therapies in patients with intracardiac thrombus: a real-world retrospective study.

Front Med (Lausanne) · 2026 · PMC12956654 · PMID 41788731

Europe PMC DOI

hedged sentences

0.0100

closest p · 0.2× alpha

0.1270

boldest claim

The sentences

a significant trendp = 0.010actually significant

Furthermore, the combination group exhibited a significant trend towards reduced all-cause mortality risk relative to the antiplatelet group (aHR 0.11, 95% CI 0.02–0.59, p = 0.010; Figure 5D ). 3.7.3.

also in 4,038 other papers

did not reach statistical significancep = 0.127not close (p > 0.1)

The combination group showed a similar direction toward improved thrombus dissolution compared with antiplatelet therapy; however, the associations did not reach statistical significance in either Model 1 (aOR 2.40, 95% CI 0.77–7.37, p = 0.127) and Model 2 (aOR 2.12, 95% CI 0.66–6.66, p = 0.199).

also in 53,799 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.